Methaqualone

Methaqualone

Methaqualone is a sedative-hypnotic drug, more commonly known by its trade name, Quaalude. It was widely prescribed in the mid-20th century as a sleep aid and for anxiety relief but later gained notoriety as a drug of abuse.

History

Methaqualone was first synthesized in India in 1950. By the 1960s, it was marketed in the United States as Quaalude and was initially seen as a safer alternative to barbiturates because of its unique chemical structure and pharmacological properties. However, its popularity led to widespread misuse and addiction.

Pharmacology

The primary therapeutic use of Methaqualone is as a sedative and hypnotic agent. Its mechanism of action is believed to involve an increase in the release of GABA, an inhibitory neurotransmitter, which can result in relaxation, sedation, and decreased anxiety.

Abuse and Legal Status

By the 1970s, Methaqualone's potential for abuse became evident. Recreational users were drawn to its euphoric and sedative effects. In the United States, due to rising concerns about its safety and potential for addiction, the Drug Enforcement Administration (DEA) classified Methaqualone as a Schedule I drug in 1984, making its production, distribution, and possession illegal without a special DEA license.

Health Risks

Misuse of Methaqualone can lead to a variety of health risks, including respiratory depression, seizures, and even fatal overdose. Combining Methaqualone with other central nervous system depressants, such as alcohol, increases the risk of life-threatening respiratory depression.

See Also

• Barbiturates
• GABA
• Drug Enforcement Administration

Methaqualone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia